Skip site navigation
University of Maryland Division of Research
Who We Are Capabilities Partnerships Resources News
Analytical Nuclear Magnetic Resonance (NMR) Service & Research Center Biomolecular Nuclear Magnetic Resonance (NMR) Facility Biosciences Cores: Genomics, Imaging, and Flow Cytometry BioWorkshop Brain & Behavior Institute - Advanced Genomic Technologies Core CALCE Test Services and Failure Analysis Laboratory Center For Innovative Biomedical Resources (CIBR) Clarice Smith Performing Arts Center Daikin Energy Innovation Lab DLAR Imaging Core Exposome Small Molecule Core Facility Glenn L. Martin Wind Tunnel Herschel S. Horowitz Center for Health Literacy KIT-Maryland MEG Lab Maryland Fire and Rescue Institute (MFRI) Maryland NanoCenter Maryland Neuroimaging Center Mass Spectrometry Facility Michelle Smith Collaboratory for Visual Culture Neutral Buoyancy Research Facility (NBRF) Surface Analysis Center The Laboratory for Biological Ultrastructure The University of Maryland Center for Health Equity The University of Maryland Prevention Research Center X-ray Crystallographic Center (XCC)
Africa Through Language and Area Studies (ATLAS) Anti-Black Racism Initiative Effective and Equitable Weather Forecasting in a Changing Climate with Machine Learning Encuentros: A University-Community Partnership to Mitigate the Mental Health Crisis for Latino Immigrant Youth Fostering Inclusivity through Technology (FIT) Helping Our Bodies Clear Respiratory Infections The Maryland Safe Drinking WATER Study Modeling the Evolution of Avian Influenza Viruses Music Education for All Through Personalized AI and Digital Humanities Observing Wildfires Through UAVs and Fire Imaging Technologies Programmable Design of Sustainable, All-Natural Plastic Substitutes Racial and Social Justice Research-Practice Partnership Collaborative Remediation of Methane, Water, and Heat Waste Seizing Opportunities: Social Capital, Businesses, and Communities Using Machine Learning to Measure and Improve Equity in K-12 Mathematics Classrooms Water Emergency Team
Accurate, Equitable, and Transparent Genetic Ancestry Inference Advancing Environmental Justice By Evaluating Climate-Ready Urban Street Trees In Historically Redlined Neighborhoods AFTER: A Hospital Violence Intervention Program For Youth Victims of Gunshot Injury An Innovative Intervention to Help Asian American Families Cope with Racism and Mental Health Difficulties Bridging the Gaps in Satellite Observations of Earth Systems to Support Climate Monitoring and Prediction Climate Change and Political Conflict Climate Mitigation and Land-Use Digital Equity Mapping Research and Training Program Establishing a Role for Psilocybin in Frontal Lobe Function Fetal Mammary Stem Cell Programming and Hormone Dysfunction Forecasting Acute Malnutrition for Anticipatory Action Genetic and Lifestyle Risk Factors of Accelerated Brain Aging in Severe Mental Illness How Does Statistical Learning Interact with Socioeconomic Status to Shape Literacy Development? Human Rights Politics and Policies: Lessons from Latin America Increasing Sustainability, Accessibility, and Equity in Urban Mobility with A Self-driving E-Scooter Increasing Participation of Minorities and Women In STEM Through Sports Performance Analytics Research Market Design, Energy Storage, and Interconnection to the U.S. Power Grid On-board Energy Harvesting for Long-endurance Earth Observation UAVs Promoting Youth Mental Wellbeing in Rural Honduras by Engaging Teachers as Catalysts Relating Attitudes on Democracy to Attitudes on Race and Ethnicity An Innovative Approach to Remove Emerging Organic Contaminants from the Environment Role of Mitochondria Dynamics in Opioid Addiction Towards an Early Warning System for Increased Probability of Community Infection by SARS-Cov-2 Variants Understanding the Impact of Wind on Fire Dynamics in Mass-Timber Compartment Visualizing Urban Flooding Due To Climate Change
Search
Who We Are Capabilities Partnerships Resources News

MPower Professor Profile: Yihua Bruce Yu, Ph.D.

Inaugural MPower Professor Uses Collaborative Approach to Improve Quality Control of Vaccines and Therapeutic Drugs

September 15, 2022

In November of 2021, University of Maryland, College Park President Darryll J. Pines and University of Maryland, Baltimore President Bruce E. Jarrell named eight professors as the inaugural MPower Professors. This award from the University of Maryland Strategic Partnership: MPowering the State (MPower) recognizes, incentivizes, and fosters faculty collaborations between the College Park and Baltimore campuses. 

Selected for his commitment to interdisciplinary and interprofessional collaboration, University of Maryland, Baltimore Professor of Pharmaceutical Sciences Yihua Bruce Yu, Ph.D. is also director of the Bio- and Nano-Technology Center in the School of Pharmacy. Dr. Yu’s expertise is in biophysics and bioengineering. In 2019, Dr. Yu joined the Institute for Bioscience and Biotechnology Research in Rockville, Md., a joint research institute between the University of Maryland and the National Institute for Standards and Technology (NIST). His lab advances the development of analytical technologies for characterizing complex drugs and vaccines. He holds multiple patents, including noninvasive analytical technologies for biologics production and inspection. In 2005, he received a U.S. Presidential Early Career Award for Scientists and Engineers.

Dr. Yihua Bruce Yu
Dr. Yihua Bruce Yu

Can you briefly describe the type of research you do?

We develop noninvasive analytical technologies for quality control of biomanufacturing and biologics, such as vaccines, and therapeutic proteins—like insulin and HUMIRA—gene and cell therapy products, and others.

Vaccines and therapeutic proteins are fragile and could be damaged during distribution and storage. Currently, there's no quality control mechanism at the point-of-care other than visual inspection. However, the damage is not always visible to the human eye. Our technology—water proton nuclear magnetic resonance (wNMR)—collects data on individual vials or syringes of vaccines or drugs, as long as they are formulated as liquid dosage forms (solutions, emulsions and suspensions) with water as the solvent. The data of each individual vial/syringe can rapidly provide an indicator of its quality.

We currently make measurements in our lab, using benchtop instruments. We also collaborate with the pharmaceutical and biotech industry. In such collaborations, we collect data using wNMR and our collaborators collect data using conventional technologies. We then compare notes with them. 

What drives you to do this research? 

We want to improve the efficiency of biomanufacturing and strengthen the quality control of biologics. We hope to eventually enable healthcare providers and patients to check on the quality of vaccines and therapeutic proteins before injection using our technology. This may enhance public confidence in vaccines and drugs and prevent certain adverse reactions.

What did it mean to you personally to be named an MPower Professor?

I'm grateful for the recognition. The funding associated with the MPower Professorship provides some flexibility for us to explore new topics and ideas that are not currently supported by external funding. For example, we explored how wNMR can assess the physicochemical properties of binary solution systems, such as water-acetonitrile. This helps us to better understand our technology.

How do you collaborate with researchers outside of your discipline, and why is this important to you?

I collaborate with people who work on other aspects of vaccines and biologics, such as discovery and development of new products. This is important because bringing people together with different areas of expertise that complement each other can lead to further discoveries.

Please name the researchers you have worked with on MPower collaborations:

  • Alexander Andrianov, Research Professor, Institute for Bioscience and Biotechnology Research, UMCP
  • Thomas Feurst, Professor, Institute for Bioscience and Biotechnology Research, UMCP
  • Eric Toth, Assistant Research Professor, Institute for Bioscience and Biotechnology Research, UMB

What are the next steps for your research?

We hope to have this technology adopted by industry, regulators, and healthcare providers. We have about 15 issued and pending patents on this technology, one of which was recently licensed by UMB to a company.

We are developing what we call preventive pharmacovigilance, the goal of which is to detect and remove poor-quality pharmaceutical products before they can reach patients. The technological basis for our approach is wNMR.